home / stock / nlbif / nlbif quote
Last: | $0.615 |
---|---|
Change Percent: | -5.38% |
Open: | $0.65 |
Close: | $0.615 |
High: | $0.65 |
Low: | $0.5355 |
Volume: | 736,774 |
Last Trade Date Time: | 06/16/2020 12:26:59 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.615 | $0.65 | $0.615 | $0.65 | $0.5355 | 736,774 | 06-15-2020 |
$0.6346 | $0.599 | $0.6346 | $0.639 | $0.599 | 45,671 | 06-11-2020 |
$0.603 | $0.732 | $0.603 | $0.7359 | $0.561 | 291,931 | 06-10-2020 |
$0.7269 | $0.85 | $0.7269 | $0.85 | $0.7043 | 137,201 | 06-09-2020 |
$0.8081 | $0.87 | $0.8081 | $0.89 | $0.7806 | 291,930 | 06-08-2020 |
$0.7787 | $0.867 | $0.7787 | $0.867 | $0.7778 | 40,223 | 06-05-2020 |
$0.735 | $0.6636 | $0.735 | $0.831 | $0.6548 | 344,225 | 06-04-2020 |
$0.6241 | $0.691 | $0.6241 | $0.691 | $0.5652 | 85,551 | 06-03-2020 |
$0.6183 | $0.58 | $0.6183 | $0.6279 | $0.5513 | 266,083 | 06-02-2020 |
$0.5398 | $0.57 | $0.5398 | $0.57 | $0.52 | 180,760 | 06-01-2020 |
$0.55 | $0.58 | $0.55 | $0.58 | $0.503 | 129,664 | 05-29-2020 |
$0.5123 | $0.594 | $0.5123 | $0.594 | $0.489 | 76,074 | 05-28-2020 |
$0.508 | $0.443 | $0.508 | $0.5137 | $0.443 | 60,154 | 05-27-2020 |
$0.451 | $0.55875 | $0.451 | $0.5588 | $0.451 | 196,040 | 05-26-2020 |
$0.5184 | $0.5115 | $0.5184 | $0.5392 | $0.4304 | 289,588 | 05-22-2020 |
$0.5115 | $0.6 | $0.5115 | $0.6 | $0.4845 | 376,334 | 05-21-2020 |
$0.597 | $0.5 | $0.597 | $0.597 | $0.3915 | 905,503 | 05-20-2020 |
$0.5661 | $0.69 | $0.5661 | $0.69 | $0.535 | 274,564 | 05-19-2020 |
$0.63 | $0.58 | $0.63 | $0.75 | $0.49 | 847,104 | 05-18-2020 |
$0.55 | $0.432 | $0.55 | $0.5851 | $0.432 | 611,677 | 05-15-2020 |
News, Short Squeeze, Breakout and More Instantly...
New Age Brands Company Name:
NLBIF Stock Symbol:
OTCMKTS Market:
DENVER, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc., ( CSE:MYCO ) ( OTC:MYCOF ) ( FSE:0NFA ) ("Mydecine" or the "Company") is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital health platform and the ...
DENVER, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-s...
DENVER, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstre...